23andMe Announces FDA Clearance of IND Application for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
January 31, 2024 07:30 ET
|
23andMe, Inc.
23ME-01473 (‘1473) seeks to treat cancer by restoring anti-tumor immunity through NK and T cells‘1473 has dual mechanisms of blocking the immunosuppressive effects of soluble ULBP6, and inducing Fc...
Fetal Bovine Serum Market Projected to Reach USD 12.9 Bn at 16.5% CAGR from 2023-2033 | Marketresearch.biz Study
January 29, 2024 02:12 ET
|
MarketResearch.biz
New York, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The fetal bovine serum market was valued at USD 2.9 billion in 2023 with significant growth and is projected to reach USD 12.9 billion by 2033 with an...
Active Pharmaceutical Ingredient Market towards a USD 839.1 Billion by 2033 | Growth driven by advancements in healthcare sector
January 23, 2024 07:47 ET
|
Market.Us
New York, Jan. 23, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global Active Pharmaceutical Ingredient market size is forecasted to exceed USD 839.1 Billion by 2033, with a promising CAGR...
Furfural Market to Reach USD 817.9 million by 2031, Registering a CAGR of 5.6%: Exclusive Report by Transparency Market Research, Inc.
January 23, 2024 03:01 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global furfural market is estimated to flourish at a CAGR of 5.6% from 2022 to 2031....
Elevar Therapeutics To Present Two Posters From Phase 3 CARES-310 Study at 2024 ASCO Gastrointestinal Cancers Symposium
January 18, 2024 08:45 ET
|
Elevar Therapeutics
A post hoc analysis found the efficacy of camrelizumab plus rivoceranib was superior to sorafenib regardless of baseline liver function as measured by both albumin-bilirubin grade and Child-Pugh...
Phenoxyethanol Market to Reach USD 329.4 million by 2031, Expanding at a CAGR of 5.1% from 2023 to 2031: Transparency Market Research, Inc.
January 16, 2024 05:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global phenoxyethanol market is estimated to flourish at a CAGR of 5.1% from 2023 to...
Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene
January 10, 2024 19:30 ET
|
Sermonix Pharmaceuticals Inc.
Partnership expands Henlius’ portfolio with license of exclusive China rights to develop, manufacture and commercialize lasofoxifene; Sermonix retains all other global rightsHenlius to facilitate...
Level Sensor Market to Reach USD 6.8 billion by 2031, Grow at a CAGR of 5.3% from 2023 to 2031 | Transparency Market Research, Inc.
January 10, 2024 03:07 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global level sensor market is estimated to flourish at a CAGR of 5.3% from 2023 to...
Trax to Prepare Pharma Companies for California Climate Reporting Regulations
January 09, 2024 15:23 ET
|
Trax
Trax’s existing use of European Sustainability Reporting Standards give
pharmaceutical companies a competitive advantage in reducing scope 3 emissions
Nanomedicine Global Market to Observe Stupendous Growth at a CAGR of ~11% by 2028 | DelveInsight
January 09, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Nanomedicine Global Market to Observe Stupendous Growth at a CAGR of ~11% by 2028 | DelveInsight Nanomedicine is experiencing heightened demand,...